PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER AUTOLOGOUS ANTI‐CD19 CAR T CELLS IN LARGE B‐CELL LYMPHOMA: A DESCAR‐T REGISTRY STUDY FORM THE LYSA

Authors: Sesques, P., Di blasi, R., Legouill, S., Cartron, G., Beauvais, D., Le Bras, F., Gros, F., Choquet, S., Bories, P., Rubio, M., Casasnovas, R., Bay, J., Mohty, M., Joris, M., Abraham, J., Llorente, C. Castilla, Loschi, M., Carras, S., Chauchet, A., Gyan, E., Zerbit, J., Hermine, O., Guidez, S., Gastinne, T., Tudesq, J., Broussais, F., Fogarty, P., Morschhauser, F., Houot, R., Thieblemont, C., Bachy, E.

Source: Hematological oncology. 41:202-204

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185003105.0x000001&indx=1&recIds=ETOCvdc_100185003105.0x000001

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Authors: Ghesquieres, H., Chevrier, M., Laadhari, M., Chinot, O., Choquet, S., Moluçon-Chabrot, C., Beauchesne, P., Gressin, R., Morschhauser, F., Schmitt, A., Gyan, E., Hoang-Xuan, K., Nicolas-Virelizier, E., Cassoux, N., Touitou, V., Le Garff-Tavernier, M., Savignoni, A., Turbiez, I., Soumelis, V., Houillier, C., Soussain, C. ^*

Source: In Annals of Oncology April 2019 30(4):621-628

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

Authors: Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., Willems, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., Haioun, C., Damaj, G., Gaulard, P., Fornecker, L., Ghesquières, H., Tournilhac, O., da Silva, M. Gomes, Bouabdallah, R., Salles, G., Bachy, E. ^*

Source: In Annals of Oncology March 2018 29(3):715-723

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group

Authors: Tchernonog, E., Faurie, P., Coppo, P., Monjanel, H., Bonnet, A., Algarte Génin, M., Mercier, M., Dupuis, J., Bijou, F., Herbaux, C., Delmer, A., Fabiani, B., Besson, C., Le Gouill, S., Gyan, E., Laurent, C., Ghesquieres, H., Cartron, G. ^*

Source: In Annals of Oncology April 2017 28(4):843-848

Topic: AS03-Health Economics & Outcome Research/AS03b-Patient-reported outcomes

Authors: Dubow, J., Guerci, A., Gyan, E., Dupuis-Sireva, A.

Source: Leukemia research. 108(S)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139835418.0x000001&indx=1&recIds=ETOCvdc_100139835418.0x000001

PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)

Authors: Pirosa, M. C., Orsucci, L., Feugier, P., Tani, M., Ghesquieres, Hervé, Musuraca, G., Baldini, L., Merli, F., Renzis, B., Gyan, E., Gini, G., Marino, D., Gressin, R., Morschhauser, F., Palombi, F., Cavallo, F., Conconi, A., Gouill, S., Tilly, Hervé, Zanni, M., Cabras, M. G., Capochiani, E., Califano, C., Molinari, A. L., Pulsoni, A., Angrilli, F., Cartron, G., Casasnovas, O., Devizzi, L., Haioun, C., Houot, R., Liberati, A. M., Occhini, U., Merli, M., Pietrantuono, G., Re, F., Spina, M., Esposito, F., Bertoni, F., Rossi, D., Ielmini, N., Luminari, S., Cavalli, F., Zucca, E., Stathis, A., Thieblemont, C.

Source: Hematological oncology. 39

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139151556.0x000001&indx=1&recIds=ETOCvdc_100139151556.0x000001

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA

Authors: Cartron, G., Bachy, E., Guidez, S., Gyan, E., Gressin, R., Morineau, N., Sibon, D., Casasnovas, O., Le Gouill, S., Tilly, H., Ysebaert, L., Schiano de Colella, J. M., Feugier, P., Virelizier, E. Nicolas, Haioun, C., Damaj, G., Tarte, K., Laurent, C., Houot, R., Thieblemont, C., Morschhauser, F., Herbaux, C.

Source: Hematological oncology. 39

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138589513.0x000001&indx=1&recIds=ETOCvdc_100138589513.0x000001

PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULATORY THERAPY CRITERIA (LYRIC) IN GATA TRIAL FROM THE LYSA GROUP

Authors: Al Tabaa, Y., Casasnovas, O., Baillet, C., Bachy, E., Virelizier, E. Nicolas, Schiano de Colella, J. M., Bailly, C., Kanoun, S., Guidez, S., Gyan, E., Gressin, R., Morineau, N., Ysebaert, L., Le Gouill, S., Tilly, H., Houot, R., Morschhauser, F., Cartron, G., Herbaux, C.

Source: Hematological oncology. 39

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138588950.0x000001&indx=1&recIds=ETOCvdc_100138588950.0x000001

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Authors: Fornecker, L., Delwail, V., Thieblemont, C., Ghesquieres, H., Bouabdallah, K., Tilly, H., Le Calloch, R., Morschhauser, F., Costello, R., Slama, B., Gyan, E., Chauchet, A., Ngirabacu, M., Durot, E., Choquet, S., Capdupuy, C., Le Goff, M., Voillat, L., Snauwaert, S., Amorim, S.

Source: Hematological oncology. 41:437-437

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185005286.0x000001&indx=1&recIds=ETOCvdc_100185005286.0x000001

Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis

Authors: Gyan, E., Andrieu, V., Sanna, A., Caille, A., Schemenau, J., Sudaka, I., Siguret, V., Malet, M., Park, S., Bordessoule, D.

Source: BRITISH JOURNAL OF HAEMATOLOGY. 175(5):975-979

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382858813&indx=1&recIds=ETOCRN382858813

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA

Authors: Trebouet, A., Marchand, T., Lemal, R., Gyan, E., Broussais-Guillaumot, F., Guillermin, Y., Monjanel, H., Salles, G., Le Gouill, S., Godmer, P., Fruchart, C., Damaj, G., Feugier, P., Thieblemont, C., Maynadié, M., Monnereau, A., Troussard, X., Rossille, D., Lamy, T., Houot, R. ^*

Source: In Annals of Oncology October 2013 24(10):2612-2618

French consensus on myelodysplasic syndrome and chronic myelomonocytic leukemia: diagnostic, classification and treatment 2015 update by the Myelodysplasia French Group

Authors: Fenaux, P., Ades, L., Fontenay, M., Raynaud, S., Eclache, V., Rose, C., Guerci-Bresler, A., Gyan, E., Robin, M., Prebet, T.

Source: Hématologie. 21(1):28-45

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN600197184&indx=1&recIds=ETOCRN600197184

French consensus on myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia: diagnosis, classification and treatment : 2015 update By the Groupe francophone des myélodysplasies (GFM)

Authors: Fenaux, P., Ades, L., Fontenay, M., Raynaud, S., Eclache, V., Rose, C., Guerci-Bresler, A., Gyan, E., Robin, M., Prebet, T.

Source: Hématologie. 21(1):46-59

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN600197197&indx=1&recIds=ETOCRN600197197

Prospective assessment of FilmArray(R) technology for the rapid identification of yeast isolated from blood cultures

Authors: Desoubeaux, G., Franck-Martel, C., Bailly, E., Le Brun, C., Gyan, E., Goudeau, A., Chandenier, J., Lanotte, P.

Source: JOURNAL OF MICROBIOLOGICAL METHODS. 106:119-122

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN360629956&indx=1&recIds=ETOCRN360629956

Urinary coproporphyrin I/(I-+-III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance

Authors: Benz-de Bretagne, I., Zahr, N., Le Gouge, A., Hulot, J. S., Houillier, C., Hoang-Xuan, K., Gyan, E., Lissandre, S., Choquet, S., Le Guellec, C.

Source: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 78(2):329-342

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN356586139&indx=1&recIds=ETOCRN356586139

Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years’ experience in a single centre

Authors: Radesi-Sarghi, S., Arbion, F., Dartigeas, C., Delain, M., Benboubker, L., Hérault, O., Colombat, P., Gyan, E.

Source: ANNALS OF HEMATOLOGY. 93(1):147-156

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN344967501&indx=1&recIds=ETOCRN344967501

Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.

Authors: Dufour, J., Choquet, S., Hoang-Xuan, K., Schmitt, A., Ahle, G., Houot, R., Taillandier, L., Gressin, R., Casasnovas, O., Marolleau, J.P., Tamburini, J., Serrier, C., Perez, E., Paillassa, J., Gyan, E., Chauchet, A., Ursu, R., Kas, A., Soussain, C., Houillier, C.

Source: Annals of Hematology; May2023, Vol. 102 Issue 5, p1159-1169, 11p

Subject Terms: PERIPHERAL nervous system, LYMPHOMAS, NON-Hodgkin's lymphoma, PROGRESSION-free survival, CENTRAL nervous system

Lymphome du MALT primitif du sein decouvert fortuitement et traite par la reduction mammaire. A propos d'un cas exceptionnel et revue de la litterature

Authors: Pessis, R., Bahe, L., Gyan, E., Zakine, G., Atlan, M.

Source: ANNALES DE CHIRURGIE PLASTIQUE ET ESTHETIQUE. 58(6):684-687

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN343219306&indx=1&recIds=ETOCRN343219306

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

Authors: Ghesquieres, H., Stamatoullas, A., Casasnovas, O., Morschhauser, F., Gyan, E., Gabarre, J., Malphettes, M., Clement, L., Ferlay, C., Brice, P.

Source: LEUKEMIA AND LYMPHOMA. 54(11):2399-2404

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN340237247&indx=1&recIds=ETOCRN340237247

Efficacy and safety of pegylated-interferon -2a in myelofibrosis: a study by the FIM and GEM French cooperative groups

Authors: Ianotto, J. C., Boyer-Perrard, F., Gyan, E., Laribi, K., Cony-Makhoul, P., Demory, J. L., Renzis, B., Dosquet, C., Rey, J., Roy, L.

Source: BRITISH JOURNAL OF HAEMATOLOGY. 162(6):783-791

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338428777&indx=1&recIds=ETOCRN338428777